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Through its life cycle from the insect vector to mammalian hosts Trypanosoma cruzi has developed
clever strategies to reach the intracellular milieu where it grows sheltered from the hosts’ immune
system. We have been interested in several aspects of  in vitro interactions of different infective forms of
the parasite with cultured mammalian cells. We have observed that not only the classically infective
trypomastigotes but also amastigotes, originated from the extracellular differentiation of trypomastigotes,
can infect cultured cells. Interestingly, the process of invasion of different parasite infective forms is
remarkably distinct and also highly dependent on the host cell type.
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In the natural course of infection, the infected
insect transmits metacyclic trypomastigotes that in-
vade mammalian cells, escape the endocytic vacu-
ole and transform into rounded amastigote forms.
Amastigotes replicate in the cytoplasm, differenti-
ate back into trypomastigotes that are released af-
ter cell lysis. An alternative sub-cycle can occur in
the mammalian host if amastigotes, originated from
premature lysis of infected cells (Behbehani 1973,
Nogueira & Cohn 1976, Carvalho et al. 1981,
Umezawa et al. 1985, Ulisses de Carvalho & De
Souza 1986) or by extracellular differentiation of
trypomastigotes (Pan 1978, Andrews et al. 1987,
Ley et al. 1988, Mortara 1991), invade professional
or non-professional phagocytes. Inside these cells
the amastigotes can survive and sustain the
parasite’s life cycle. These amastigote-like infec-
tive forms present morphological, immunological,
biochemical and ultrastructural similarities to in-
tracellular amastigotes (Villalta & Kierszenbaum,
1982, 1984, Hudson et al. 1984, Andrews et al.
1987, Ley et al. 1988) and express specific mo-
lecular markers of amastigotes (Andrews et al.
1987, Lima et al. 1988, Pan & McMahon-Pratt
1989). We have seen that extracellular amastigotes
are able to infect HeLa cells by interacting with
microvilli on the dorsal surface of these cells
(Mortara 1991). This association leads to microvil-
lus aggregation that can be followed by microfila-
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ment clustering observed by phalloidin staining.
By contrast, trypomastigotes preferentially enter
HeLa cells at the edges showing that the different
forms of the parasite interact with specific regions
of the cell surface (Mortara 1991). Differences in
invasion mechanisms utilized by extracellular
amastigotes and metacyclic trypomastigotes be-
came even more apparent when we tested the re-
quirement for integrity of host cells’ cytoskeleton.
For that HeLa and Vero cells were treated with
drugs that disrupt microfilaments or microtubules.
Mammalian cells with altered expression in actin-
binding proteins (Actin-Binding Protein, ABP, and
gelsolin) were also tested as target cells. Protein
kinase inhibitors (staurosporine and genistein) in-
terfered with the invasion processes. The distribu-
tion of different host cell components during the
invasion by the two parasite forms was consistent
with the emerging notion that extracellular
amastigotes and metacyclic trypomastigotes utilize
mechanisms to invade host cells with highly dis-
tinctive features for each Trypanosoma cruzi  form
and for each host cell. Preliminary data from our
studies also suggest that culture-derived
trypomastigotes and metacyclic trypomastigotes
may form parasito-phorous vacuoles with distinct
properties.
MATERIALS AND METHODS
Vero, HeLa, Actin-binding mutants and
transfectants, gelsolin transfectants, Coxiella
burnetti-chronically infected Vero cells were rou-
tinely grown in DME or RPMI-1640 media supple-
mented with fetal calf serum and antibiotics when
necessary. Parasites from different T. cruzi strains
were maintained in LIT medium and trypo-
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mastigotes generated by infecting Vero cells.
Amastigotes were obtained from infected cells (in-
tracellular) or after 48 hr incubation of tissue-cul-
ture trypomastigotes in LIT medium at 37ºC (ex-
tracellular).
RESULTS AND DISCUSSION
We have started our study trying to understand
how extracellular amastigotes invade mammalian
cells. Earlier work from several groups indicated
that this is a common observation and we decided
to initiate our studies by comparing the mechanism
of cell invasion with that of metacyclic
trypomastigotes, the vectorial infective form ex-
tensively studied by our colleagues.
It was initially observed that intracellular
amastigotes of several strains were poorly infec-
tive to non-phagocytic cells and extracellular
amastigotes of the highly infective CL strain were
much less invasive than G-strain derived parasites.
Interestingly, the infectivity to HeLa cells of ex-
tracellular amastigotes correlated with the expres-
sion of a carbohydrate epitope defined by  mono-
clonal antibody 1D9 (Barros et al. 1997, Verbisck
et al. 1998) (Figure).
The infectivity of extracellular amastigotes and
metacyclic trypomastigotes of the G strain towards
different mammalian target cells was then system-
atically examined. We observed that amastigotes
normally displayed a higher capability of invasion
on most cells. The effect of  drugs that interfere
with microfilament (cytochalasin D) or microtu-
bule (nocodazole) assembly on the invasion of the
two infective forms was also not only cell (HeLa
or Vero) but also infective form dependent
(Procópio et al. 1998).
We also tested cells with modified expression
in microfilament-associated components (gelsolin
and actin-binding protein, ABP) as target cells and
again observed contrasting results with the two
infective forms of the parasite. Drugs that inter-
fere with protein phosphorylation (genistein and
staurosporine) also displayed contrasting effects
(Procópio et al. 1998).
The recruitment of extracellular matrix com-
ponents of HeLa and Vero cells, their integrin re-
ceptors and cytoskeletal elements was examined
under electron and confocal fluorescence micros-
copy and significant differences were again found
in the pattern involving either trypomastigote or
extracellular amastigote invasion (Procópio et al.
1998).
We have also began to examine the formation
and escape from the parasitophorous vacuole by
the infective forms. We observed that whilst ex-
tracellular amastigotes and metacyclic trypo-
mastigotes are found in LAMP-1 positive compart-
ments after 1 hr following infection, extracellular
amastigotes appear to  escape faster from the vacu-
ole than metecyclics do. Moreover, preliminary
results using Vero cells chronically infected with
the ryckettsia C.  burnetti that induce the forma-
tion of large and highly fusogenic cytoplasmic
vacuoles (Veras et al. 1994, 1995) has disclosed
an unforeseen feature of trypomastigote invasion.
Indeed, metacyclic trypomastigotes (CL strain) are
much more efficiently transferred from the extra-
cellular medium to the C. burnetti vacuole than
the corresponding tissue-culture derived
trypomastigotes under identical conditions. If this
observation is confirmed, it would imply that the
composition of the parasitophorous membrane in-
volving the two types of trypomastigotes is dis-
tinct.
These studies have thus emphasized the notion
that the mechanism involved in the entry of differ-
ent T. cruzi infective forms depends not only on
the host cell but also on the parasite stage.
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